SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurogen (NRGN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (378)12/2/2003 2:16:16 AM
From: Doc Bones  Read Replies (1) of 523
 
Wow! No wonder a somewhat similar company, NTII, was also feeling feisty today. Even a biotech outsider could match them by company name.

I've read about how MRK was the most research-oriented pharma, but having problems with their pipeline, and not interested in mega-mergers. e.g.

#reply-19542482

It occurred to me that MRK might have the best chance of productive partnerships with small biotechs. They would be a more simpatico partner for a biotech than a PFE or similar behemoths.

Hopefully this will work out for both.

Doc
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News